Skip to main content
. 2020 Jun;20(2):549–559. doi: 10.4314/ahs.v20i2.2

Table 4.

Percentage drug resistance for non-nucleoside reverse transcriptase inhibitors (NNRTIs)

Resistance level
(%)
Low Intermediate High Susceptible
Efavirenz 4.8 14.3 71.4 9.5
Etravirine 57.1 14.3 4.8 23.8
Nevirapine 4.8 9.5 76.2 9.5
Rilpivirine 38.1 19.1 19.1 23.8